BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation announced today that they are in the final planning and approval stages of a randomized clinical study for the treatment of pulmonary embolism, known as the ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism (ULTIMA) Study.
